Tavros Therapeutics and OpenBench Expand Strategic Collaboration for Small Molecule Drug Discovery

Tavros Therapeutics was co-founded by Dr. Eoin McDonnell, graduate of the Duke University Molecular Cancer Biology PhD Program.